The Board of Directors (the “Board”) of Impact Healthcare REIT plc (ticker: IHR) is pleased to announce that all the resolutions put to General Meeting of shareholders held earlier today were duly passed.
Votes (by proxy and in person) were validly received in respect of 49,865,415 ordinary shares in the capital of the Company (“Ordinary Shares”), representing approximately 31.1 per cent. of the issued Ordinary Shares.
a) Percentages are expressed as a proportion of the total votes cast (which does not include votes withheld).
b) A “vote withheld” is not a vote in law and is not counted in the calculation of the proportion of the votes “For” and “Against” a resolution. c) Any proxy appointments which gave discretion to the Chairman have been included in the “For” totals.
All capitalised terms in this announcement and not otherwise defined shall have the meaning given to them in the Circular. Full details of the Resolutions are set out in the circular published by the Company on 16 October 2017 (the “Circular”). A copy of the Circular is available for inspection in electronic form on the Investors section of the Company’s website and on the National Storage Mechanism at www.morningstar.co.uk/uk/NSM.
For further information please contacts:
Impact Health Partners LLP via Newgate Communications
Winterﬂood Securities Limited
Tel: 020 3100 0000
Newgate Communications (PR Adviser)
Tel: 020 7680 6550
The Company’s LEI is 213800AX3FHPMJL4IJ53.
Further information on Impact Healthcare REIT is available at www.impactreit.uk
The Company is a real estate investment trust (“REIT”) which aims to provide shareholders with an attractive return, principally in the form of quarterly income distributions and with the potential for capital and income growth, through exposure to a diversified portfolio of healthcare real estate opportunities, in particular residential care homes. The Company’s investment policy is to acquire, renovate, extend and redevelop high quality healthcare real estate assets in the UK and lease those assets primarily to healthcare operators providing residential healthcare services under full
repairing and insuring leases.
The Company is targeting an aggregate dividend of 6.0 pence per share for the first 12 months from Admission which equates to a yield of 6 per cent. per annum on the IPO Issue Price, payable in quarterly instalments(1).
The Company’s IPO in March 2017 raised gross proceeds of £160 million. The Company’s Ordinary Shares were admitted to trading on the main market of the London Stock Exchange, in the Specialist Fund Segment on 7 March 2017.
(1) This is a target only and not a profit forecast and there can be no assurance that it will be met and it should not be taken as an indication of the Company’s actual or expected future results.